Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $11.2 million.

  • Solesence's Cost of Revenue rose 430.14% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year increase of 3792.26%. This contributed to the annual value of $36.2 million for FY2024, which is 2268.93% up from last year.
  • As of Q3 2025, Solesence's Cost of Revenue stood at $11.2 million, which was up 430.14% from $14.5 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Cost of Revenue registered a high of $14.5 million during Q2 2025, and its lowest value of $4.6 million during Q2 2021.
  • In the last 5 years, Solesence's Cost of Revenue had a median value of $7.3 million in 2023 and averaged $8.0 million.
  • In the last 5 years, Solesence's Cost of Revenue skyrocketed by 12471.6% in 2021 and then crashed by 1395.73% in 2024.
  • Quarter analysis of 5 years shows Solesence's Cost of Revenue stood at $6.2 million in 2021, then grew by 17.77% to $7.3 million in 2022, then increased by 3.32% to $7.5 million in 2023, then increased by 29.99% to $9.8 million in 2024, then increased by 14.55% to $11.2 million in 2025.
  • Its Cost of Revenue stands at $11.2 million for Q3 2025, versus $14.5 million for Q2 2025 and $11.2 million for Q1 2025.